BioLineRx (BLRX) Interest & Investment Income (2011 - 2026)
BioLineRx (BLRX) recorded Interest & Investment Income of $132,000 in the quarter ended Jun 30, 2026, down 73.1% from $490,000 a year earlier and down 36.5% from the prior quarter.
Powered by 
Analysis
BioLineRx (BLRX) Interest & Investment Income (2011 - 2026) Analysis & Trends
On a TTM basis, BioLineRx's Interest & Investment Income came in at $1.02 million as of Jun 30, 2026, down 34.4% year-over-year; for the year ended Dec 31, 2025, it came in at $1.46 million, down 21.8% from the prior year.
- Annual Interest & Investment Income has a five-year compound annual growth rate of 44.1% (years ended Dec 2020 to Dec 2025).
- Across earlier years, Interest & Investment Income came in at $1.87 million in the year ended Dec 31, 2024 (-9.5%), $2.07 million in the year ended Dec 31, 2023 (+198.0%), $694,000 in the year ended Dec 31, 2022 (+24.2%) and $559,000 in the year ended Dec 31, 2021 (+136.9%).
- The figure for the quarter ended Jun 30, 2026 is the lowest quarterly Interest & Investment Income since the quarter ended Sep 30, 2022.
- On a year-over-year basis, Interest & Investment Income has declined for seven consecutive quarters, with an average decline of 24.9% over the last eight quarters.
- Peak year-over-year performance for Interest & Investment Income in the last five years was growth of 701.5% in the quarter ended Mar 31, 2023, against a decline of 73.1% in the quarter ended Jun 30, 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $208,000 (quarter ended Mar 31, 2026), $303,000 (quarter ended Dec 31, 2025) and $377,000 (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | BioLineRx | 6.06 Bn | 6.06 Bn | 235,000.00 | 132,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 132,000.00 |
| Mar 31, 2026 | 208,000.00 |
| Dec 31, 2025 | 303,000.00 |
| Sep 30, 2025 | 377,000.00 |
| Jun 30, 2025 | 490,000.00 |
| Mar 31, 2025 | 294,000.00 |
| Dec 31, 2024 | 337,000.00 |
| Sep 30, 2024 | 434,000.00 |
| Jun 30, 2024 | 535,000.00 |
| Mar 31, 2024 | 565,000.00 |
| Dec 31, 2023 | 779,000.00 |
| Sep 30, 2023 | 312,000.00 |
| Jun 30, 2023 | 440,000.00 |
| Mar 31, 2023 | 537,000.00 |
| Dec 31, 2022 | 438,000.00 |
| Sep 30, 2022 | 109,000.00 |
| Jun 30, 2022 | 80,000.00 |
| Mar 31, 2022 | 67,000.00 |
| Dec 31, 2021 | 260,000.00 |
| Sep 30, 2021 | 52,000.00 |
API Access
BioLineRx Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();